Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients.
<h4>Background</h4>Receptor activator of NFkB (RANK), its ligand (RANKL) and the decoy receptor of RANKL (osteoprotegerin, OPG) play a pivotal role in bone remodeling by regulating osteoclasts formation and activity. RANKL stimulates migration of RANK-expressing tumor cells in vitro, con...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2011
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/45452be1c44f4935936ddba940a7b305 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:45452be1c44f4935936ddba940a7b305 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:45452be1c44f4935936ddba940a7b3052021-11-18T06:54:46ZReceptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients.1932-620310.1371/journal.pone.0019234https://doaj.org/article/45452be1c44f4935936ddba940a7b3052011-04-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21559440/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Receptor activator of NFkB (RANK), its ligand (RANKL) and the decoy receptor of RANKL (osteoprotegerin, OPG) play a pivotal role in bone remodeling by regulating osteoclasts formation and activity. RANKL stimulates migration of RANK-expressing tumor cells in vitro, conversely inhibited by OPG.<h4>Materials and methods</h4>We examined mRNA expression levels of RANKL/RANK/OPG in a publicly available microarray dataset of 295 primary breast cancer patients. We next analyzed RANK expression by immunohistochemistry in an independent series of 93 primary breast cancer specimens and investigated a possible association with clinicopathological parameters, bone recurrence and survival.<h4>Results</h4>Microarray analysis showed that lower RANK and high OPG mRNA levels correlate with longer overall survival (P = 0.0078 and 0.0335, respectively) and disease-free survival (P = 0.059 and 0.0402, respectively). Immunohistochemical analysis of RANK showed a positive correlation with the development of bone metastases (P = 0.023) and a shorter skeletal disease-free survival (SDFS, P = 0.037). Specifically, univariate analysis of survival showed that "RANK-negative" and "RANK-positive" patients had a SDFS of 105.7 months (95% CI: 73.9-124.4) and 58.9 months (95% CI: 34.7-68.5), respectively. RANK protein expression was also associated with accelerated bone metastasis formation in a multivariate analysis (P = 0.029).<h4>Conclusions</h4>This is the first demonstration of the role of RANK expression in primary tumors as a predictive marker of bone metastasis occurrence and SDFS in a large population of breast cancer patients.Daniele SantiniGaia SchiavonBruno VincenziLaura GaetaFrancesco PantanoAntonio RussoCinzia OrtegaCamillo PortaSara GalluzzoGrazia ArmentoNicla La VerdeCinzia CarotiIsabelle TreilleuxAlessandro RuggieroGiuseppe PerroneRaffaele AddeoPhilippe ClezardinAndrea Onetti MudaGiuseppe ToniniPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 4, p e19234 (2011) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Daniele Santini Gaia Schiavon Bruno Vincenzi Laura Gaeta Francesco Pantano Antonio Russo Cinzia Ortega Camillo Porta Sara Galluzzo Grazia Armento Nicla La Verde Cinzia Caroti Isabelle Treilleux Alessandro Ruggiero Giuseppe Perrone Raffaele Addeo Philippe Clezardin Andrea Onetti Muda Giuseppe Tonini Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. |
| description |
<h4>Background</h4>Receptor activator of NFkB (RANK), its ligand (RANKL) and the decoy receptor of RANKL (osteoprotegerin, OPG) play a pivotal role in bone remodeling by regulating osteoclasts formation and activity. RANKL stimulates migration of RANK-expressing tumor cells in vitro, conversely inhibited by OPG.<h4>Materials and methods</h4>We examined mRNA expression levels of RANKL/RANK/OPG in a publicly available microarray dataset of 295 primary breast cancer patients. We next analyzed RANK expression by immunohistochemistry in an independent series of 93 primary breast cancer specimens and investigated a possible association with clinicopathological parameters, bone recurrence and survival.<h4>Results</h4>Microarray analysis showed that lower RANK and high OPG mRNA levels correlate with longer overall survival (P = 0.0078 and 0.0335, respectively) and disease-free survival (P = 0.059 and 0.0402, respectively). Immunohistochemical analysis of RANK showed a positive correlation with the development of bone metastases (P = 0.023) and a shorter skeletal disease-free survival (SDFS, P = 0.037). Specifically, univariate analysis of survival showed that "RANK-negative" and "RANK-positive" patients had a SDFS of 105.7 months (95% CI: 73.9-124.4) and 58.9 months (95% CI: 34.7-68.5), respectively. RANK protein expression was also associated with accelerated bone metastasis formation in a multivariate analysis (P = 0.029).<h4>Conclusions</h4>This is the first demonstration of the role of RANK expression in primary tumors as a predictive marker of bone metastasis occurrence and SDFS in a large population of breast cancer patients. |
| format |
article |
| author |
Daniele Santini Gaia Schiavon Bruno Vincenzi Laura Gaeta Francesco Pantano Antonio Russo Cinzia Ortega Camillo Porta Sara Galluzzo Grazia Armento Nicla La Verde Cinzia Caroti Isabelle Treilleux Alessandro Ruggiero Giuseppe Perrone Raffaele Addeo Philippe Clezardin Andrea Onetti Muda Giuseppe Tonini |
| author_facet |
Daniele Santini Gaia Schiavon Bruno Vincenzi Laura Gaeta Francesco Pantano Antonio Russo Cinzia Ortega Camillo Porta Sara Galluzzo Grazia Armento Nicla La Verde Cinzia Caroti Isabelle Treilleux Alessandro Ruggiero Giuseppe Perrone Raffaele Addeo Philippe Clezardin Andrea Onetti Muda Giuseppe Tonini |
| author_sort |
Daniele Santini |
| title |
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. |
| title_short |
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. |
| title_full |
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. |
| title_fullStr |
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. |
| title_full_unstemmed |
Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. |
| title_sort |
receptor activator of nf-kb (rank) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2011 |
| url |
https://doaj.org/article/45452be1c44f4935936ddba940a7b305 |
| work_keys_str_mv |
AT danielesantini receptoractivatorofnfkbrankexpressioninprimarytumorsassociateswithbonemetastasisoccurrenceinbreastcancerpatients AT gaiaschiavon receptoractivatorofnfkbrankexpressioninprimarytumorsassociateswithbonemetastasisoccurrenceinbreastcancerpatients AT brunovincenzi receptoractivatorofnfkbrankexpressioninprimarytumorsassociateswithbonemetastasisoccurrenceinbreastcancerpatients AT lauragaeta receptoractivatorofnfkbrankexpressioninprimarytumorsassociateswithbonemetastasisoccurrenceinbreastcancerpatients AT francescopantano receptoractivatorofnfkbrankexpressioninprimarytumorsassociateswithbonemetastasisoccurrenceinbreastcancerpatients AT antoniorusso receptoractivatorofnfkbrankexpressioninprimarytumorsassociateswithbonemetastasisoccurrenceinbreastcancerpatients AT cinziaortega receptoractivatorofnfkbrankexpressioninprimarytumorsassociateswithbonemetastasisoccurrenceinbreastcancerpatients AT camilloporta receptoractivatorofnfkbrankexpressioninprimarytumorsassociateswithbonemetastasisoccurrenceinbreastcancerpatients AT saragalluzzo receptoractivatorofnfkbrankexpressioninprimarytumorsassociateswithbonemetastasisoccurrenceinbreastcancerpatients AT graziaarmento receptoractivatorofnfkbrankexpressioninprimarytumorsassociateswithbonemetastasisoccurrenceinbreastcancerpatients AT niclalaverde receptoractivatorofnfkbrankexpressioninprimarytumorsassociateswithbonemetastasisoccurrenceinbreastcancerpatients AT cinziacaroti receptoractivatorofnfkbrankexpressioninprimarytumorsassociateswithbonemetastasisoccurrenceinbreastcancerpatients AT isabelletreilleux receptoractivatorofnfkbrankexpressioninprimarytumorsassociateswithbonemetastasisoccurrenceinbreastcancerpatients AT alessandroruggiero receptoractivatorofnfkbrankexpressioninprimarytumorsassociateswithbonemetastasisoccurrenceinbreastcancerpatients AT giuseppeperrone receptoractivatorofnfkbrankexpressioninprimarytumorsassociateswithbonemetastasisoccurrenceinbreastcancerpatients AT raffaeleaddeo receptoractivatorofnfkbrankexpressioninprimarytumorsassociateswithbonemetastasisoccurrenceinbreastcancerpatients AT philippeclezardin receptoractivatorofnfkbrankexpressioninprimarytumorsassociateswithbonemetastasisoccurrenceinbreastcancerpatients AT andreaonettimuda receptoractivatorofnfkbrankexpressioninprimarytumorsassociateswithbonemetastasisoccurrenceinbreastcancerpatients AT giuseppetonini receptoractivatorofnfkbrankexpressioninprimarytumorsassociateswithbonemetastasisoccurrenceinbreastcancerpatients |
| _version_ |
1718424224991805440 |